CREST-2 (clinicaltrials.gov number: NCT02089217) is a pair of parallel, actively recruiting procedural trials to prevent stroke comparing: 1) carotid endarterectomy (CEA) and intensive medical ...
Adding stenting to intensive medical therapy significantly improves outcomes among patients with asymptomatic high-grade carotid stenosis compared with drug treatment alone, a bar not met by carotid ...
For decades, the management of asymptomatic carotid stenosis sat in a gray zone: older trials suggested a small benefit of carotid endarterectomy (CEA) over standard medical therapy, but improvements ...
NEW ORLEANS, LA—Revascularization with either stenting or endarterectomy does not improve cognitive function compared with medical management alone in patients who have asymptomatic high-grade carotid ...
TEL AVIV, Israel and MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today ...
Interventional cardiologist Dr. Amir Haghighat said the findings favor stenting for patients with significant blockage.